In a review of recently published scientific studies, researchers at Columbia Engineering and the University of Wisconsin-Madison identified a library of molecules that can shut down the polymerase reaction in the SARS-CoV-2 virus that causes COVID-19.

Recent personnel movement within the healthcare industry includes a new CEO for Scenic Biotech.

The European Commission gave conditional approval for the use of remdesivir in severe COVID-19 patients following an accelerated review process, making the antiviral the region’s first authorized therapy to treat the virus.

COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government’s top infectious diseases expert said.

Only a few weeks after announcing receipt of a green light from the U.S. Food and Drug Administration to begin a 30,000-patient Phase III clinical trial of a COVID-19 vaccine, Moderna indicated the start date was pushed back.

The United States reported more than 55,000 new COVID-19 casesy, a new daily global record for the coronavirus pandemic, as infections rose in a majority of states.